Pii: S0168-8278(02)00114-9

patients receiving high dose induction followed by combination interferon and ribavirin therapy Hugo R. Rosen*, Ruy R. Ribeiro, Leor Weinberger, Stephanie Wolf, Minjun Chung, David R. Gretch, Alan S. Perelson Division of Gastroenterology and Hepatology, Portland Veterans Affairs Medical Center, Portland, OR, USA Division of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA Viral Hepatitis Laboratory, University of Washington, Seattle, WA, USA